Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Richard Vandlen
Development of a Two-Part Strategy to Identify a Therapeutic Human Bispecific Antibody That Inhibits IgE Receptor Signaling
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Related publications
Development of an Antibody That Neutralizes Soluble IgE and Eliminates IgE Expressing B Cells
Cellular and Molecular Immunology
Infectious Diseases
Medicine
Allergy
Immunology
IgE-dependent Signaling as a Therapeutic Target for Allergies
Trends in Pharmacological Sciences
Toxicology
Pharmacology
A Potent Antagonist of Protease-Activated Receptor 2 That Inhibits Multiple Signaling Functions in Human Cancer Cells
Journal of Pharmacology and Experimental Therapeutics
Molecular Medicine
Pharmacology
A Novel Bispecific Antibody Against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
PLoS ONE
Multidisciplinary
Antitumor Activity of a Novel Bispecific Antibody That Targets the ErbB2/ErbB3 Oncogenic Unit and Inhibits Heregulin-Induced Activation of ErbB3
Molecular Cancer Therapeutics
Cancer Research
Oncology
A Bispecific Antibody to Link a TRAIL-Based Antitumor Approach to Immunotherapy
Frontiers in Immunology
Allergy
Immunology
Lysophosphatidic Acid Receptor 5 Inhibits B Cell Antigen Receptor Signaling and Antibody Response
Journal of Immunology
Allergy
Immunology
A Multi-Targeted Probe-Based Strategy to Identify Signaling Vulnerabilities in Cancers
Journal of Biological Chemistry
Biochemistry
Cell Biology
Molecular Biology
Strategy to Enhance the Therapeutic Effect of Doxorubicin in Human Hepatocellular Carcinoma by Selenocystine, a Synergistic Agent That Regulates the ROS-mediated Signaling
Oncotarget
Oncology
